A randomised, open label, two-period, cross-over, multi-centre study to compare correct inhaler handling of fluticasone/ formoterol breath-actuated inhaler (K-haler) with that of Symbicort Turbohaler in subjects with persistent asthma, ACOS or COPD.

Trial Profile

A randomised, open label, two-period, cross-over, multi-centre study to compare correct inhaler handling of fluticasone/ formoterol breath-actuated inhaler (K-haler) with that of Symbicort Turbohaler in subjects with persistent asthma, ACOS or COPD.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary) ; Budesonide
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Mundipharma Research
  • Most Recent Events

    • 16 Sep 2017 Status changed from recruiting to completed.
    • 20 Oct 2016 This trial has been restarted in Germany.
    • 20 Apr 2016 This trial is suspended in Germany ,according to European Clinical Trials Database
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top